Evidence map›Paper›PMID 40951576›Full record

SynthesisArchives of Razi Institute2025

The Prevalence of

B Hosseinpour Aghaei, N Taiefi Nasrabadi, Y Pirali, S S Shojaei

Abstract readSystematic Review
In one paragraph

Synthesis in Archives of Razi Institute, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The Prevalence ofArchives of Razi Institute · 2025
    Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

B Hosseinpour AghaeiDepartment of pathobiology, Karaj branch, Islamic Azad University, Karaj, Iran.
N Taiefi NasrabadiDepartment of pathobiology, Karaj branch, Islamic Azad University, Karaj, Iran.
Y PiraliDepartment of Pathobiology, Faculty of Veterinary Medicine, Shahrekord University, Shahrekord, Iran.
S S ShojaeiDepartment of pathobiology, Karaj branch, Islamic Azad University, Karaj, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fasciolosis, a foodborne parasitic disease, is caused by the trematodes Fasciola hepatica and Fasciola gigantica. This disease is of significant concern, having been reported in various vertebrate hosts across more than 80 countries. A comparison of the geographical distribution of the two species reveals that Fasciola hepatica affects a wider range of animals and is often reported from high altitudes and hot and humid areas. The present study endeavors to provide an update on fascioliasis in animal and human hosts in Iran during the years 2019 to 2024. A systematic search of published articles in English was conducted using electronic databases including Google Scholar, PubMed, Iran Science Direct, SID and Magiran. Following a thorough review of the literature, a total of 18 articles were identified that satisfied the predetermined inclusion criteria for the evaluation of the prevalence of fascioliasis in humans and animals within the Iranian context. Of the 18 articles that were subjected to analysis, only five documented the presence of the Fasciola hepatica species. In four articles, researchers encountered difficulties in identifying the specific species of Fasciola. Notably, the remaining articles reported the presence of both F. hepatica and F. gigantica species. The molecular analysis was employed in 61.1% of the cases, which is noteworthy. The prevalence of human fascioliasis exhibited variability, ranging from 1.7% to 2.4% across diverse regions of Iran. The present systematic review revealed that there has been a paucity of studies conducted in the field of fasciolosis in Iran during the last five years. Consequently, the authors of the present study recommend the implementation of further research focusing on the prevalence of fasciolosis in all provinces. The authors further recommend the formulation and dissemination of effective prevention and control strategies for this disease, contingent on the prevalence of fasciolosis in different provinces.

Indexed as

Cattle DiseasesFasciolaFascioliasisLivestockAnimalsHumansIranPrevalenceFasciolosisHuman LivestockPrevalence

Identifiers

PMID40951576
PMCPMC12426428

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.